Literature DB >> 15665058

Regression of pressure overload-induced left ventricular hypertrophy in mice.

Xiao-Ming Gao1, Helen Kiriazis, Xiao-Lei Moore, Xin-Heng Feng, Karen Sheppard, Anthony Dart, Xiao-Jun Du.   

Abstract

As a prelude to investigating the mechanism of regression of pressure overload-induced left ventricular (LV) hypertrophy (LVH), we studied the time course for the development and subsequent regression of LVH as well as accompanying alterations in cardiac function, histology, and gene expression. Mice were subjected to aortic banding for 4 or 8 wk to establish LVH, and regression was initiated by release of aortic banding for 6 wk. Progressive increase in LV mass and gradual chamber dilatation and dysfunction occurred after aortic banding. LVH was also associated with myocyte enlargement, interstitial fibrosis, and enhanced expression of atrial natriuretic peptide, collagen I, collagen III, and matrix metalloproteinase-2 but suppressed expression of alpha-myosin heavy chain and sarcoplasmic reticulum Ca(2+)-ATPase. Aortic debanding completely or partially reversed LVH, chamber dilatation and dysfunction, myocyte size, interstitial fibrosis, and gene expression pattern, each with a distinct time course. The extent of LVH regression was dependent on the duration of pressure overload, evidenced by the fact that restoration of LV structure and function was complete in animals subjected to 4 wk of aortic banding but incomplete in animals subjected to 8 wk of aortic banding. In conclusion, LVH regression comprises a variety of morphological, functional, and genetic components that show distinct time courses. A longer period of pressure overload is associated with a slower rate of LVH regression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15665058     DOI: 10.1152/ajpheart.00836.2004

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  31 in total

1.  Interferon-γ ablation exacerbates myocardial hypertrophy in diastolic heart failure.

Authors:  Anthony G Garcia; Richard M Wilson; Joline Heo; Namita R Murthy; Simoni Baid; Noriyuki Ouchi; Flora Sam
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-06-22       Impact factor: 4.733

2.  Normalization of cardiac substrate utilization and left ventricular hypertrophy precede functional recovery in heart failure regression.

Authors:  Nikole J Byrne; Jody Levasseur; Miranda M Sung; Grant Masson; Jamie Boisvenue; Martin E Young; Jason R B Dyck
Journal:  Cardiovasc Res       Date:  2016-03-10       Impact factor: 10.787

3.  Predictions of hypertrophy and its regression in response to pressure overload.

Authors:  Kyoko Yoshida; Andrew D McCulloch; Jeffrey H Omens; Jeffrey W Holmes
Journal:  Biomech Model Mechanobiol       Date:  2019-12-07

4.  Functional significance of the discordance between transcriptional profile and left ventricular structure/function during reverse remodeling.

Authors:  Veli K Topkara; Kari T Chambers; Kai-Chien Yang; Huei-Ping Tzeng; Sarah Evans; Carla Weinheimer; Attila Kovacs; Jeffrey Robbins; Philip Barger; Douglas L Mann
Journal:  JCI Insight       Date:  2016-04-06

5.  Effects of ketamine-xylazine intravenous bolus injection on cardiovascular function in rabbits.

Authors:  Christine Baumgartner; Melanie Bollerhey; Johanna Ebner; Lién Laacke-Singer; Tibor Schuster; Wolf Erhardt
Journal:  Can J Vet Res       Date:  2010-07       Impact factor: 1.310

6.  Myocardial perfusion MRI shows impaired perfusion of the mouse hypertrophic left ventricle.

Authors:  Bastiaan J van Nierop; Bram F Coolen; Noortje A Bax; Wouter J R Dijk; Elza D van Deel; Dirk J Duncker; Klaas Nicolay; Gustav J Strijkers
Journal:  Int J Cardiovasc Imaging       Date:  2014-01-28       Impact factor: 2.357

7.  Periostin is a novel factor in cardiac remodeling after experimental and clinical unloading of the failing heart.

Authors:  William E Stansfield; Nancy M Andersen; Ru-Hang Tang; Craig H Selzman
Journal:  Ann Thorac Surg       Date:  2009-12       Impact factor: 4.330

8.  Chronic inhibition of the Na+/H+ - exchanger causes regression of hypertrophy, heart failure, and ionic and electrophysiological remodelling.

Authors:  A Baartscheer; M Hardziyenka; C A Schumacher; C N W Belterman; M M G J van Borren; A O Verkerk; R Coronel; J W T Fiolet
Journal:  Br J Pharmacol       Date:  2008-05-19       Impact factor: 8.739

9.  Knockout of beta(1)- and beta(2)-adrenoceptors attenuates pressure overload-induced cardiac hypertrophy and fibrosis.

Authors:  H Kiriazis; K Wang; Q Xu; X-M Gao; Z Ming; Y Su; X-L Moore; G Lambert; M E Gibbs; A M Dart; X-J Du
Journal:  Br J Pharmacol       Date:  2008-01-14       Impact factor: 8.739

10.  Chronic activation of the low affinity site of β1-adrenoceptors stimulates haemodynamics but exacerbates pressure-overload cardiac remodelling.

Authors:  Helen Kiriazis; Niquita Tugiono; Qi Xu; Xiao-Ming Gao; Nicole L Jennings; Ziqui Ming; Yidan Su; Paul Klenowski; Roger J Summers; Alberto Kaumann; Peter Molenaar; Xiao-Jun Du
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.